Abstract:Age-related bone loss and disease strongly affect the quality of life of the elderly population. Cellular circadian rhythms have been reported to regulate bone aging, and micro RNAs (miRNAs) play crucial posttranscriptional regulatory roles in the peripheral clock network. Proliferation capability, osteogenic lineage commitment, senescence-associated secreted phenotype (SASP) and circadian oscillation of clock genes under osteogenic condition were assessed in bone marrow mesenchymal stromal cells (BMSCs) from young adult and aged adult mice. miRNAs targeting the core clock gene brain and muscle arntl-like protein 1 (Bmal1) were screened and verified in young and old BMSCs with RT-qPCR and Western Blot analysis. ChIP-seq and RNA-seq datasets were mined to define the downstream mechanism and gain- and loss-of-function genetic experiments were performed to confirm the hypothesis. To compare the therapeutic effect of these clock-engineered BMSCs, SASP and osteogenic capability of Bmal1-overexpressing and miR-142-3p-inhibited BMSCs were investigated in vitro and transplanted into bone defects and femur cavities of aged mice. Aged BMSCs displayed an abolished circadian rhythm, impaired self-renewal capability and decreased osteoblast differentiation. miR-142-3p was elevated with aging, which downregulated Bmal1 and diminished the osteogenic potential of BMSCs. In addition, Bmal1 inhibited YAP expression to promote BMSCs osteogenesis, which was independent from the activation of Hippo signaling pathway. Overexpression of Bmal1 or inhibition of miR-142-3p rescued the molecular temporal rhythm and osteoblast differentiation ex vivo. Cell-based circadian therapy showed improved bone formation and higher turnover levels in vivo. This study demonstrates that transcriptional and post-transcriptional level clock-modified BMSCs rescued circadian oscillation and age-related bone loss via miR-142-3p/Bmal1/YAP signaling axis. These data provide promising clinical prospects of circadian-mediated stromal cell-based therapy and bone tissue regeneration.

The Circadian Clock Component BMAL1 Regulates Osteogenesis in Osseointegration

BMP Signaling in the Development and Regeneration of Cranium Bones and Maintenance of Calvarial Stem Cells.

The biological function of BMAL1 in skeleton development and disorders

Epigenetically Modified Bone Marrow Stromal Cells in Silk Scaffolds Promote Craniofacial Bone Repair and Wound Healing

Circadian BMAL1 Regulates Mandibular Condyle Development by Hedgehog Pathway

Enhanced Circadian Clock in MSCs-Based Cytotherapy Ameliorates Age-Related Temporomandibular Joint Condyle Degeneration.

Postnatal Conditional Deletion of Bmal1 in Osteoblasts Enhances Trabecular Bone Formation Via Increased BMP2 Signals.

Clock-modified Mesenchymal Stromal Cells Therapy Rescues Molecular Circadian Oscillation and Age-Related Bone Loss Via Mir142-3P/bmal1/yap Signaling Axis

Effect of the clock genes on the bone remodeling

BMAL1 Deficiency Promotes Skeletal Mandibular Hypoplasia Via OPG Downregulation

BMAL1 regulates osteoblast differentiation through mTOR/GSK3/-catenin pathway

BMAL1 Regulates Osteoblast Differentiation Through Mtor/gsk3β/β-Catenin Pathway.

Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis

Circadian rhythms affect bone reconstruction by regulating bone energy metabolism

Effects of BMAL1 on dentinogenic differentiation of dental pulp stem cells via PI3K/Akt/mTOR pathway

Bmal1 Promotes Cementoblast Differentiation and Cementum Mineralization Via Wnt/β-catenin Signaling

Circadian Rhythm Protein Bmal1 Modulates Cartilage Gene Expression in Temporomandibular Joint Osteoarthritis Via the MAPK/ERK Pathway

BMAL1 Deficiency Contributes to Mandibular Dysplasia by Upregulating MMP3

BMAL1-TTK-H2Bub1 Loop Deficiency Contributes to Impaired BM-MSC-mediated Bone Formation in Senile Osteoporosis

Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function